Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005132070Aexternal-prioritypatent/JP3818657B2/en
Priority claimed from JP2005298472Aexternal-prioritypatent/JP4024810B2/en
Application filed by Nippon Zoki Pharmaceutical CofiledCriticalNippon Zoki Pharmaceutical Co
Publication of TW200626127ApublicationCriticalpatent/TW200626127A/en
Application grantedgrantedCritical
Publication of TWI440454BpublicationCriticalpatent/TWI440454B/en
The present invention is aimed to provide a dried material of an extract of the inflammatory skin of rabbits inoculated with viral vaccine, which has inhibitory effect on kallikrein production, and a method for producing the same. In order to produce an oral solid preparation containing an extract of the inflammatory skin of rabbits inoculated with viral vaccine as the active ingredient, the present invention provides a method for producing a dried material of said extract, comprising, during drying, adding sugar, sugar alcohol or ascorbic acid to the extract before the extract is completely dried. By this method, a dried material having inhibitory effect on kallikrein production can be obtained, and said dried material can be used in production of an oral solid preparation such as a tablet.
TW94141677A2004-12-012005-11-28Dried material and method for producing the same
TWI440454B
(en)
Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency